Course Description
Award Finalists
Innovative Practices Award Finalist
3:15-3:35 p.m.: Morgan C. Snyder, PharmD, Resident, The University of Texas at Austin College of Pharmacy, Austin, TX
Application of STOPP Criteria in Comparison to Beers Criteria in an Inpatient Psychiatric Facility and Impact on Utilization of Potentially Inappropriate Medications and Adverse Outcomes
Therapeutic Case Report Award Finalists
3:35-3:55 p.m.: Jonathan G. Leung, PharmD, BCPP, BCPS, Psychiatric Clinical Pharmacist, Western Psychiatric Institute and Clinic/University of Pittsburgh Medical Center, Pittsburgh, PA
Donepezil as a Precipitating Factor of Mania: A Case Report
3:55-4:15 p.m.: Amber Riesselman, PharmD, Assistant Professor, Sullivan University College of Pharmacy, Louisville, KY
"Closing-in" on clozapine dosing: a case warranting therapeutic drug monitoring
Learning Objectives
- Discuss new research in the field of psychopharmacology.
- Relate the outcomes of this research into clinical practice.
- Review a novel clinical case and its implications related to treatment.
- Identify innovative pharmacy practice models and discuss their role in clinical practice.
Faculty
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
Activity Date: 04/30/2012
ACPE Contact Hours: 1
ACPE Number: 0284-9999-12-011-L04-P (Knowledge)
ACCME:1 AMA PRA Category 1 Credit(s)™
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
ACPE Credit
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The 2012 Annual Meeting will provide up to 14 contact hours (1.4 CEUs) of knowledge- and application-based continuing education credit from CPNP approved programming. The pre-meeting workshop is provided for an additional 7 contact hours (0.7 CEUs) and when combined with all other CPNP programming, allows for a maximum achievable 18 contact hours (1.8 CEUs). Industry supported symposia offered at the Annual Meeting offer additional ACPE credit.
To receive a statement of credit, participants must verify their attendance at the programming and complete evaluations and self-assessment questions. ACPE statements of credit will be retrieved by participants online on the CPNP website within one month following the event.
CME Credit
Sponsored by the University of Arizona College of Medicine at the Arizona Health Sciences Center.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint sponsorship of The University of Arizona College of Medicine at the Arizona Health Sciences Center and the College of Psychiatric and Neurologic Pharmacists. The University of Arizona College of Medicine at the Arizona Health Sciences Center is accredited by the ACCME to provide continuing medical education for physicians.
The University of Arizona College of Medicine at the Arizona Health Sciences Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s).™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
ACPE and ACCME approved contact hours are accepted for ANCC Certification Renewal (as quoted on the ANCC website): “Other health disciplines' continuing education hours may be used if the content is applicable to your area of certification. ACPE and ACCME are specifically listed as approved credit types.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View disclaimer and disclosure of off-label use
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patientâs conditions and possible contraindications on dangers in use, review of any applicable manufacturerâs product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.